Ferulic acid loaded Poly-d,l-lactide-co-glycolide nanoparticles: Systematic study of particle size, drug encapsulation efficiency and anticancer effect in non-small cell lung carcinoma cell line in vitro - 14/03/12
, S.M.A. Shibli b, Mol Sebeela b
Corresponding author. Phone: +91 9842305384, Fax: +91 4144 239141.Abstract |
Ferulic acid (FA) is a phenolic phytonutrient, which possesses strong anticancer effect. However, its prominent application in cancer is limited due to poor bioavailability at the tumor site. The aim of the present study was to develop FA-PLGA nanoparticles and to study its anticancer efficacy in NCI-H460 cells in vitro. FA-PLGA nanoparticles were prepared by double emulsion method and characterized by dynamic light scattering (DLS) and the prepared FA-PLGA had an average size of 483nm. Transmission electron microscope (TEM) analysis showed the prepared FA-PLGA nanoparticles were spherical in shape with 200nm. Drug encapsulation assay showed that 76% FA was encapsulated in PLGA. Further, FA-PLGA exhibits increased intracellular reactive oxygen species (ROS) levels, altered mitochondrial transmembrane potential (MMP), increased DNA damage, enhanced TBARS and apoptotic morphological changes in NCI-H460 cells when compared to FA treatment alone. Our results indicate that FA-PLGA demonstrated increased anticancer property in cancer cells than FA treatment alone.
Le texte complet de cet article est disponible en PDF.Keywords : Nanoparticles (NPs), Anticancer, Chemotherapy, Ferulic acid (FA), Poly-D,L-lactide-co-glycolide (PLGA)
Plan
Vol 2 - N° 1
P. 69-76 - janvier 2012 Retour au numéro
Article précédent
- Ethanolic neem (Azadirachta indica A. Juss) leaf extract induces apoptosis and inhibits the IGF signaling pathway in breast cancer cell lines
- Perumal Elumalai, Dharmalingam Nandagopal Gunadharini, Kalimuthu Senthilkumar, Sivanantham Banudevi, Ramachandran Arunkumar, Chellakkan Selvanesan Benson, Govindaraj Sharmila, Jagadeesan Arunakaran
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?